Archives

by in
Entry Author Date Location
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Dendreon Shares Fall Again, as Provenge Sales Slump 05/09/13 Seattle
Biotech in the Belt-Tightening Era: The Photos 04/12/13 Seattle
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Adaptive Biotechnologies Reaches Fork in the Road. What to Charge? 04/03/13 Seattle
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Biotech & Pharma Whining About Talent: That Makes Me Mad 02/18/13 National
East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More 02/15/13 National
Join Us at “Biotech in the Belt-Tightening Era” April 9 in Seattle 02/14/13 Seattle
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride 01/28/13 National
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
The Best Boring Companies in Biotech 07/09/12 National
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Emerging Challenges of Prostate Cancer Drug Development 06/06/12 National
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Why Would a Biotech Company Go the Trouble of Changing Its Name? 06/04/12 National
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Good for Some, Good for All 05/24/12 Seattle
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say 05/16/12 Seattle
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Page 1 of 10 next page »